221 studies found for:    DIABETES MELLITUS, NONINSULIN-DEPENDENT, 3
Show Display Options
Rank Status Study
1 Recruiting Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease.
Conditions: Type 2 Diabetes;   Cardiovascular Diseases
Intervention: Dietary Supplement: Omega-3 PUFA
2 Completed Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Drug: Pioglitazone
3 Recruiting Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes
Conditions: Diabetes Mellitus Type 2;   Hypertension
Interventions: Dietary Supplement: Ginseng;   Dietary Supplement: Wheat Bran
4 Completed n-3 Fatty Acid Infusion and Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Dietary Supplement: Intralipid +/- Omegaven
5 Completed Metabolic Response to 3-day Fast Versus Carbohydrate-free Diet in Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Other: 3 day fast;   Other: 3 day CHO-free diet
6 Completed Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Placebo group(once daily);   Drug: LC15-0444 50mg  qd
7 Completed
Has Results
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ranolazine;   Drug: Placebo to match ranolazine;   Drug: Metformin;   Drug: Placebo to match metformin;   Behavioral: Diet;   Behavioral: Exercise
8 Not yet recruiting Adult Accuracy Study of the Enlite 3 Glucose Sensor
Conditions: Type 1 Diabetes;   Type 2 Diabetes
Interventions: Device: Enlite 3;   Device: Guardian Mobile App;   Device: 640G Insulin Pump
9 Active, not recruiting Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes
Condition: Type 2 Diabetes
Interventions: Dietary Supplement: Vitamin D3;   Drug: Omega-3 fatty acid (fish oil);   Dietary Supplement: Vitamin D3 placebo;   Drug: Fish oil placebo
10 Completed Effects of N-3 Polyunsaturated Fatty Acids On Chylomicron Secretion And Expression Of Genes That Regulate Intestinal Lipid Metabolism In Men With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Dietary Supplement: n-3 PUFAs;   Dietary Supplement: Placebo
11 Completed Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Drug: AC2993;   Drug: Placebo
12 Completed Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
Condition: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Drug: AC2993;   Drug: Placebo
13 Unknown  Effects of 3 Months of Supervised Exercise Training
Conditions: Overweight/Obesity;   Glucose Intolerance;   Type 2 Diabetes;   Sedentarity
Intervention: Behavioral: Behavior: Supervised physical training
14 Recruiting A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ertugliflozin;   Drug: Placebo
15 Enrolling by invitation The Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics
Condition: Type 2 Diabetes
Interventions: Dietary Supplement: omega-3;   Dietary Supplement: placebo
16 Completed Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans
Conditions: Healthy;   Type 2 Diabetes Mellitus
Intervention: Drug: Metformin
17 Completed
Has Results
Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)
Condition: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Drug: sitagliptin phosphate;   Behavioral: Comparator: Diet;   Behavioral: Comparator: Physical Activity
18 Active, not recruiting A Comprehensive Longitudinal Cohort Study in Type 2 Diabetes With High Risk of Cardiovascular Diseases in China
Condition: Type 2 Diabetes
Intervention:
19 Completed Impact of 3-Year Lifestyle Intervention on Postprandial Glucose Metabolism: the SLIM Study
Conditions: Impaired Glucose Tolerance;   Type 2 Diabetes
Intervention: Behavioral: diet- and exercise intervention
20 Completed
Has Results
The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
Condition: Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Drug: insulin glargine (HOE901);   Drug: omega-3 polyunsaturated fatty acids (PUFA);   Drug: placebo;   Device: reusable pen device for insulin injection

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years